Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Arecor Therapeutics PLC ( (GB:AREC) ) has shared an announcement.
Arecor Therapeutics plc announced it will release its audited final results for the year ended 31 December 2024 on 22 April 2025. The announcement will include an in-person briefing for analysts, along with a live webcast and conference call, indicating the company’s commitment to transparency and engagement with stakeholders.
More about Arecor Therapeutics PLC
Arecor Therapeutics plc is a biopharmaceutical company focused on transforming patient care by bringing innovative medicines to market. Utilizing its proprietary technology platform, Arestat™, Arecor enhances existing therapeutic products and develops a portfolio of proprietary products in diabetes and other areas. The company collaborates with leading pharmaceutical and biotechnology firms to deliver therapeutic solutions.
YTD Price Performance: -48.30%
Average Trading Volume: 17,219
Technical Sentiment Signal: Strong Buy
Current Market Cap: £14.35M
For detailed information about AREC stock, go to TipRanks’ Stock Analysis page.